AHR and non-small cell lung carcinoma: Ahr overexpression has been associated with human NSCLC by sustaining cell stemness through Jak/Stat3 [21], by mediating the toxic effects of benzo-[a]-pyrene [22] and through the upregulation of metabolizing enzymes such as CYP1B1 [23,24].